196 related articles for article (PubMed ID: 19895766)
1. Drinking histories in alcohol-use-disordered youth: preliminary findings on relationships to platelet serotonin transporter expression with genotypes of the serotonin transporter.
Dawes MA; Roache JD; Javors MA; Bergeson SE; Richard DM; Mathias CW; Ait-Daoud N; Dougherty DM; Johnson BA
J Stud Alcohol Drugs; 2009 Nov; 70(6):899-907. PubMed ID: 19895766
[TBL] [Abstract][Full Text] [Related]
2. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?
Johnson BA; Javors MA; Roache JD; Seneviratne C; Bergeson SE; Ait-Daoud N; Dawes MA; Ma JZ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):209-16. PubMed ID: 17950969
[TBL] [Abstract][Full Text] [Related]
3. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.
Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939
[TBL] [Abstract][Full Text] [Related]
4. Serotonin transporter polymorphism and bleeding time during SSRI therapy.
Hougardy DM; Egberts TC; van der Graaf F; Brenninkmeijer VJ; Derijks LJ
Br J Clin Pharmacol; 2008 May; 65(5):761-6. PubMed ID: 18279474
[TBL] [Abstract][Full Text] [Related]
5. Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity.
Preuss UW; Soyka M; Bahlmann M; Wenzel K; Behrens S; de Jonge S; Krüger M; Bondy B
Psychiatry Res; 2000 Sep; 96(1):51-61. PubMed ID: 10980326
[TBL] [Abstract][Full Text] [Related]
6. Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers.
Patkar AA; Berrettini WH; Mannelli P; Gopalakrishnan R; Hoehe MR; Bilal L; Weinstein S; Vergare MJ
Psychiatr Genet; 2004 Mar; 14(1):25-32. PubMed ID: 15091312
[TBL] [Abstract][Full Text] [Related]
7. Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder.
Coccaro EF; Lee R; Kavoussi RJ
J Psychiatr Res; 2010 Feb; 44(3):137-42. PubMed ID: 19767013
[TBL] [Abstract][Full Text] [Related]
8. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia.
Anderson GM; Gutknecht L; Cohen DJ; Brailly-Tabard S; Cohen JH; Ferrari P; Roubertoux PL; Tordjman S
Mol Psychiatry; 2002; 7(8):831-6. PubMed ID: 12232775
[TBL] [Abstract][Full Text] [Related]
9. Can serotonin transporter genotype predict craving in alcoholism?
Ait-Daoud N; Roache JD; Dawes MA; Liu L; Wang XQ; Javors MA; Seneviratne C; Johnson BA
Alcohol Clin Exp Res; 2009 Aug; 33(8):1329-35. PubMed ID: 19426172
[TBL] [Abstract][Full Text] [Related]
10. Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study.
Kenna GA; Zywiak WH; Swift RM; McGeary JE; Clifford JS; Shoaff JR; Vuittonet C; Fricchione S; Brickley M; Beaucage K; Haass-Koffler CL; Leggio L
Alcohol Clin Exp Res; 2014 Jun; 38(6):1567-74. PubMed ID: 24773166
[TBL] [Abstract][Full Text] [Related]
11. Interactive effects of citalopram and serotonin transporter genotype on neural correlates of response inhibition and attentional orienting.
Fischer AG; Endrass T; Goebel I; Reuter M; Montag C; Kubisch C; Ullsperger M
Neuroimage; 2015 Aug; 116():59-67. PubMed ID: 25957993
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets.
Greenberg BD; Tolliver TJ; Huang SJ; Li Q; Bengel D; Murphy DL
Am J Med Genet; 1999 Feb; 88(1):83-7. PubMed ID: 10050973
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.
Johnson BA; Ait-Daoud N; Seneviratne C; Roache JD; Javors MA; Wang XQ; Liu L; Penberthy JK; DiClemente CC; Li MD
Am J Psychiatry; 2011 Mar; 168(3):265-75. PubMed ID: 21247998
[TBL] [Abstract][Full Text] [Related]
14. Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria.
Melke J; Westberg L; Landén M; Sundblad C; Eriksson O; Baghei F; Rosmond R; Eriksson E; Ekman A
Psychoneuroendocrinology; 2003 Apr; 28(3):446-58. PubMed ID: 12573307
[TBL] [Abstract][Full Text] [Related]
15. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine.
Whale R; Quested DJ; Laver D; Harrison PJ; Cowen PJ
Psychopharmacology (Berl); 2000 May; 150(1):120-2. PubMed ID: 10867985
[TBL] [Abstract][Full Text] [Related]
16. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.
Heinz A; Jones DW; Mazzanti C; Goldman D; Ragan P; Hommer D; Linnoila M; Weinberger DR
Biol Psychiatry; 2000 Apr; 47(7):643-9. PubMed ID: 10745057
[TBL] [Abstract][Full Text] [Related]
17. Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation.
Janssen PK; Bakker SC; Réthelyi J; Zwinderman AH; Touw DJ; Olivier B; Waldinger MD
J Sex Med; 2009 Jan; 6(1):276-84. PubMed ID: 19170855
[TBL] [Abstract][Full Text] [Related]
18. The 5HTTLPR polymorphism, psychopathologic symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes.
Steiger H; Joober R; Israël M; Young SN; Ng Ying Kin NM; Gauvin L; Bruce KR; Joncas J; Torkaman-Zehi A
Int J Eat Disord; 2005 Jan; 37(1):57-60. PubMed ID: 15690467
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the serotonin transporter polymorphism and obsessive-compulsive alcohol craving in alcohol-dependent adults: a pilot study.
Thompson RD; Heffner JL; Strong JA; Blom TJ; Anthenelli RM
Alcohol; 2010 Aug; 44(5):401-6. PubMed ID: 20598843
[TBL] [Abstract][Full Text] [Related]
20. A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline.
Kenna GA; Zywiak WH; McGeary JE; Leggio L; McGeary C; Wang S; Grenga A; Swift RM
Alcohol Clin Exp Res; 2009 Feb; 33(2):315-23. PubMed ID: 19032576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
